Koch Institute investigators are working across disciplines to combine nanotechnology and novel drug combinations to improve patient care. Discover how the team’s Trojan horse approach sneaks across the blood brain barrier and packs a one-two punch that hits glioblastoma cancer cells while their defenses are down.
6:30 PM — 7:30 PM
Join via Zoom.
Paula T. Hammond, PhD, Head, MIT Department of Chemical Engineering; David H. Koch Professor of Engineering; Member, Marble Center for Cancer Nanomedicine
Fred Chiu-Lai Lam, MD, Clinical Scholar, Division of Neurosurgery, McMaster University; Research Scientist, Koch Institute
Moderated by: Michael B. Yaffe, MD, PhD, Director, Koch Institute Clinical Investigator Program; Director, MIT Center for Precision Cancer Medicine; David H. Koch Professor of Science; Professor of Biology and Biological Engineering
